Merck Offloads Slower-Growing Products into New Company

GALWAY, IRELAND--February 18, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Merck (NYSE: MRK) is planning to spin-off its women's health, older legacy products and biosimilar drugs into a new, independent publicly traded company.

Within this article: Details new spin off company, revenues, proposed savings, focus on faster growing drugs like Keytruda